Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0324 per EA under NDC 67877022305. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877022305
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA090858On Market Since
1/29/2011
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0324 per EA |
|---|---|
| All-time high | $0.0676 (Feb 12, 2014) |
| All-time low | $0.0313 (Nov 20, 2024) |
| 52-week high | $0.0361 |
| 52-week low | $0.0324 |
| Median price | $0.0454 |
| Average price | $0.0459 |
| Largest weekly change | +18.3% (Jan 22, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0324 per EA (NDC 67877022305), effective Jun 24, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 42.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0313 (Nov 20, 2024) to a high of $0.0676 (Feb 12, 2014), with a median of $0.0454 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
17 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 67877022305) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification